Apollo Hospitals Enterprise Stock Fundamentals
| APOLLOHOSP | 6,935 192.60 2.86% |
Apollo Hospitals Enterprise fundamentals help investors to digest information that contributes to Apollo Hospitals' financial success or failures. It also enables traders to predict the movement of Apollo Stock. The fundamental analysis module provides a way to measure Apollo Hospitals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Apollo Hospitals stock.
As of now, Apollo Hospitals' Total Revenue is increasing as compared to previous years. The Apollo Hospitals' current Gross Profit is estimated to increase to about 97.2 B, while Selling General Administrative is projected to decrease to under 1.4 B. Apollo | Select Account or Indicator |
Apollo Hospitals Enterprise Company Current Valuation Analysis
Apollo Hospitals' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Apollo Hospitals Current Valuation | 1.01 T |
Most of Apollo Hospitals' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Apollo Hospitals Enterprise is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Apollo Hospitals Enterprise has a Current Valuation of 1.01 T. This is much higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The current valuation for all India stocks is significantly lower than that of the firm.
Apollo Hospitals Ent Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Apollo Hospitals's current stock value. Our valuation model uses many indicators to compare Apollo Hospitals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Apollo Hospitals competition to find correlations between indicators driving Apollo Hospitals's intrinsic value. More Info.Apollo Hospitals Enterprise is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.44 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Apollo Hospitals Enterprise is roughly 2.29 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Apollo Hospitals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Apollo Hospitals' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Apollo Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Apollo Hospitals' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Apollo Hospitals could also be used in its relative valuation, which is a method of valuing Apollo Hospitals by comparing valuation metrics of similar companies.Apollo Hospitals is currently under evaluation in current valuation category among its peers.
Apollo Fundamentals
| Return On Equity | 0.17 | ||||
| Return On Asset | 0.0723 | ||||
| Profit Margin | 0.06 % | ||||
| Operating Margin | 0.11 % | ||||
| Current Valuation | 1.01 T | ||||
| Shares Outstanding | 143.78 M | ||||
| Shares Owned By Insiders | 30.73 % | ||||
| Shares Owned By Institutions | 47.97 % | ||||
| Price To Book | 12.92 X | ||||
| Price To Sales | 4.87 X | ||||
| Revenue | 190.59 B | ||||
| Gross Profit | 59.85 B | ||||
| EBITDA | 24.02 B | ||||
| Net Income | 8.99 B | ||||
| Cash And Equivalents | 483 M | ||||
| Total Debt | 53.33 B | ||||
| Book Value Per Share | 499.31 X | ||||
| Cash Flow From Operations | 19.2 B | ||||
| Earnings Per Share | 82.26 X | ||||
| Target Price | 7921.76 | ||||
| Number Of Employees | 83.15 K | ||||
| Beta | 0.6 | ||||
| Market Capitalization | 997.16 B | ||||
| Total Asset | 167.53 B | ||||
| Retained Earnings | 39.11 B | ||||
| Working Capital | 6.15 B | ||||
| Annual Yield | 0 % | ||||
| Net Asset | 167.53 B | ||||
| Last Dividend Paid | 10.0 |
About Apollo Hospitals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Apollo Hospitals Enterprise's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Apollo Hospitals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Apollo Hospitals Enterprise based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 1.4 B | 1.3 B | |
| Total Revenue | 190.6 B | 200.1 B | |
| Cost Of Revenue | 98.1 B | 103 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Apollo Stock
Apollo Hospitals financial ratios help investors to determine whether Apollo Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Apollo with respect to the benefits of owning Apollo Hospitals security.